HB1809

Summary

A New Hampshire bill to establish a medical psilocybin advisory board was killed by the Senate on May 7, 2026. The bill's defeat means no formal state assessment of therapeutic psilocybin will move forward in New Hampshire at this time, leaving the substance without a regulatory pathway.

More New Hampshire Cannabis Bills

• HB186Relative to the legalization and regulation of cannabis and making appropriations therefor.In Committee
• SB650Relative to use of cannabis products for therapeutic purposes by alternative treatment centers.Introduced
• SB651Relative to the legalization and regulation of cannabis and making appropriations therefor.Introduced
• HB1796Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.Introduced
• HB1446Providing that an individual's use of therapeutic cannabis shall not disqualify the individual from the purchase, ownership, or possession of a firearm.Introduced
• CACR19Relative to the personal possession of cannabis. Providing that adults 21 years of age or older shall have the right to possess a modest amount of cannabis intended for their personal consumption.Introduced
• HB1235Legalizing certain quantities of cannabis.Introduced
• SB485Relative to the licensure, regulation and taxation of hemp-based derivative products.Introduced
• SB462Relative to the right of therapeutic cannabis patients to purchase, possess, and transfer firearms in accordance with state law.Introduced